381 related articles for article (PubMed ID: 34453155)
1. Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry.
Khoo A; Liu LY; Nyalwidhe JO; Semmes OJ; Vesprini D; Downes MR; Boutros PC; Liu SK; Kislinger T
Nat Rev Urol; 2021 Dec; 18(12):707-724. PubMed ID: 34453155
[TBL] [Abstract][Full Text] [Related]
2. Proteomics in diagnosis of prostate cancer.
Davalieva K; Polenakovic M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
4. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
[TBL] [Abstract][Full Text] [Related]
6. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
7. Emerging proteomics biomarkers and prostate cancer burden in Africa.
Adeola HA; Blackburn JM; Rebbeck TR; Zerbini LF
Oncotarget; 2017 Jun; 8(23):37991-38007. PubMed ID: 28388542
[TBL] [Abstract][Full Text] [Related]
8. On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances.
Yan Y; Yeon SY; Qian C; You S; Yang W
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948334
[TBL] [Abstract][Full Text] [Related]
9. Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis.
Troyer DA; Mubiru J; Leach RJ; Naylor SL
Dis Markers; 2004; 20(2):117-28. PubMed ID: 15322319
[TBL] [Abstract][Full Text] [Related]
10. Improving Clinical Risk Stratification at Diagnosis in Primary Prostate Cancer: A Prognostic Modelling Study.
Gnanapragasam VJ; Lophatananon A; Wright KA; Muir KR; Gavin A; Greenberg DC
PLoS Med; 2016 Aug; 13(8):e1002063. PubMed ID: 27483464
[TBL] [Abstract][Full Text] [Related]
11. Advances in proteomic prostate cancer biomarker discovery.
Goo YA; Goodlett DR
J Proteomics; 2010 Sep; 73(10):1839-50. PubMed ID: 20398807
[TBL] [Abstract][Full Text] [Related]
12. In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice.
Katafigioti A; Katafigiotis I; Sfoungaristos S; Alamanis C; Stravodimos K; Anastasiou I; Roumelioti E; Duvdevani M; Constantinides C
Arch Ital Urol Androl; 2016 Oct; 88(3):195-200. PubMed ID: 27711093
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers of prostate cancer.
Bradford TJ; Tomlins SA; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(6):538-51. PubMed ID: 17138135
[TBL] [Abstract][Full Text] [Related]
14. Novel biomarkers for prostate cancer: An evidence-based review for use in clinical practice.
Narayan VM; Konety BR; Warlick C
Int J Urol; 2017 May; 24(5):352-360. PubMed ID: 28345187
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathology of prostate cancer.
Cazares LH; Drake RR; Esquela-Kirscher A; Lance RS; Semmes OJ; Troyer DA
Cancer Biomark; 2010; 9(1-6):441-59. PubMed ID: 22112489
[TBL] [Abstract][Full Text] [Related]
16. Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports.
Minnee P; Hessels D; Schalken JA; Van Criekinge W
BMC Urol; 2019 Nov; 19(1):124. PubMed ID: 31783839
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers for the detection and prognosis of prostate cancer.
Hernandez J; Canby-Hagino E; Thompson IM
Curr Urol Rep; 2005 May; 6(3):171-6. PubMed ID: 15869720
[TBL] [Abstract][Full Text] [Related]
18. Clinical collection and protein properties of expressed prostatic secretions as a source for biomarkers of prostatic disease.
Drake RR; White KY; Fuller TW; Igwe E; Clements MA; Nyalwidhe JO; Given RW; Lance RS; Semmes OJ
J Proteomics; 2009 Aug; 72(6):907-17. PubMed ID: 19457353
[TBL] [Abstract][Full Text] [Related]
19. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
20. Mass Spectrometry-Based Glycoproteomics and Prostate Cancer.
Gabriele C; Prestagiacomo LE; Cuda G; Gaspari M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
